Breaking News Instant updates and real-time market news.

BABA

Alibaba

$182.49

0.01 (0.01%)

13:00
11/14/19
11/14
13:00
11/14/19
13:00

$5.5M buy in Alibaba calls possibly closes

$5.5M buy in Alibaba calls possibly closes. Initiator paid $9.20 for 5955 Jan 185 calls this morning on the PHLX when shares were $183.93. Possibly closing as 14K are open at the strike, most from last month when shares were in the 165-175 range.

  • 19

    Nov

BABA Alibaba
$182.49

0.01 (0.01%)

11/01/19
RHCO
11/01/19
NO CHANGE
Target $212
RHCO
Buy
Alibaba continues to execute in 'challenging backdrop', says SunTrust
SunTrust analyst Youssef Squali nudged his price target on Alibaba higher to $212 from $210 and kept his Buy rating after its Q2 results, saying the company is executing "very well against a challenging macro backdrop" while also gaining market share. The analyst notes that the secular growth drivers for Alibaba, including rising China consumption and "digitization" of retail, are still in place, with added support from "healthy" household balance sheets. Squali believes that the company remains on track for "outsized" growth for years to come.
11/04/19
STFL
11/04/19
NO CHANGE
Target $220
STFL
Buy
Stifel says Alibaba's more aggressive spending already priced in
Stifel analyst Scott Devitt said that comments made by Alibaba along with the company's fiscal second quarter report about aggressive spending in the back half of the fiscal year may cause concern for some investors, but he believes the more aggressive spending expectations are already largely priced into those consensus estimates. He added that the company reported a "solid" Q2 and he sees the company's investments in local services, international, logistics, and new retail strengthening the platform and expanding Alibaba's reach. Devitt keeps a Buy rating on Alibaba shares, but trimmed his price target for the stock to $220 from $225, primarily due to foreign exchange impacts.
11/11/19
BARD
11/11/19
NO CHANGE
Target $200
BARD
Outperform
Alibaba Singles Day growth decelerating modestly, says Baird
Baird analyst Colin Sebastian said that Alibaba appears on track to report year-over-year "Singles Day" growth in gross merchandise volume of about 20%, or 18% in U.S. dollars. While this level of growth represents a deceleration from last year's 27%, or 22% in U.S. dollars, it is also a "less drastic" slowdown than last year's compared to the 39% growth rate in 2017, pointed out Sebastian. He also notes that an increasing portion of this year's Singles Day growth is coming from lower tier cities, adding that he views the slowdown as reflective of Alibaba's increasingly large base. Sebastian keeps an Outperform rating on Alibaba shares with a $200 price target.
11/11/19
RAJA
11/11/19
NO CHANGE
RAJA
Strong Buy
Alibaba Singles Day growth likely beat investor expectations, says Raymond James
Raymond James analyst Aaron Kessler said he believes Alibaba's "solid" 26% year-over-year growth in local currency in Alibaba's Singles Day gross merchandise volume is ahead of investor expectations and leaves him comfortable with his customer management and commission revenues estimate of 86.7B RMB for the December quarter, which will be the company's fiscal third quarter. He reiterates a Strong Buy rating on Alibaba shares and continues to identify the stock as a Top Pick.

TODAY'S FREE FLY STORIES

VTNR

Vertex Energy

$1.59

(0.00%)

07:05
12/09/19
12/09
07:05
12/09/19
07:05
Initiation
Vertex Energy initiated  »

Vertex Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$38.20

-0.01 (-0.03%)

07:05
12/09/19
12/09
07:05
12/09/19
07:05
Conference/Events
AT&T management to meet with UBS »

Dinner Meeting with CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 29

    Jan

NOW

ServiceNow

$272.19

-0.94 (-0.34%)

07:03
12/09/19
12/09
07:03
12/09/19
07:03
Conference/Events
ServiceNow management to meet with UBS »

Dinner Meeting with Chief…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 12

    Dec

RCKT

Rocket Pharmaceuticals

$22.37

2.61 (13.21%)

07:03
12/09/19
12/09
07:03
12/09/19
07:03
Hot Stocks
Rocket Pharmaceuticals announces preliminary data from RP-L201 Phase 1/2 trial »

Rocket Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGIO

Agios Pharmaceuticals

$40.93

0.81 (2.02%)

07:03
12/09/19
12/09
07:03
12/09/19
07:03
Recommendations
Agios Pharmaceuticals analyst commentary  »

Cantor sees Agios trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 13

    Dec

AGIO

Agios Pharmaceuticals

$40.93

0.81 (2.02%)

07:01
12/09/19
12/09
07:01
12/09/19
07:01
Recommendations
Agios Pharmaceuticals analyst commentary  »

Agios Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 13

    Dec

CI

Cigna

$198.96

3.44 (1.76%)

07:00
12/09/19
12/09
07:00
12/09/19
07:00
Conference/Events
Cigna management to meet with Stephens »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 06

    Feb

AMAT

Applied Materials

$56.60

0.77 (1.38%)

06:59
12/09/19
12/09
06:59
12/09/19
06:59
Conference/Events
Applied Materials management to meet with UBS »

Breakfast Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CGC

Canopy Growth

$18.65

0.07 (0.38%)

, STZ

Constellation Brands

$183.60

1.13 (0.62%)

06:58
12/09/19
12/09
06:58
12/09/19
06:58
Recommendations
Cantor sees over 66% chance of Constellation bidding for Canopy Growth »

Cantor Fitzgerald analyst…

CGC

Canopy Growth

$18.65

0.07 (0.38%)

STZ

Constellation Brands

$183.60

1.13 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

MTG

MGIC Investment

$14.10

-0.03 (-0.21%)

06:58
12/09/19
12/09
06:58
12/09/19
06:58
Hot Stocks
MGIC Investment issues November operating statistics »

MGIC Investment issued an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ZION

Zions Bancorp

$49.71

0.43 (0.87%)

06:56
12/09/19
12/09
06:56
12/09/19
06:56
Conference/Events
Zions Bancorp management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

EGRX

Eagle Pharmaceuticals

$56.38

0.85 (1.53%)

06:55
12/09/19
12/09
06:55
12/09/19
06:55
Hot Stocks
Eagle Pharmaceuticals commences dosing in pilot study of fulvestrant »

Eagle Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YY

YY

$58.68

-0.7 (-1.18%)

06:54
12/09/19
12/09
06:54
12/09/19
06:54
Conference/Events
YY management to meet with Benchmark »

Group Breakfast Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

THO

Thor Industries

$67.76

2.17 (3.31%)

06:54
12/09/19
12/09
06:54
12/09/19
06:54
Earnings
Thor Industries reports Q1 EPS 92c, consensus $1.23 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

WTER

Alkaline Water

$1.13

0.01 (0.89%)

06:51
12/09/19
12/09
06:51
12/09/19
06:51
Conference/Events
Alkaline Water management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

FTV

Fortive

$72.86

0.5 (0.69%)

06:50
12/09/19
12/09
06:50
12/09/19
06:50
Upgrade
Fortive rating change  »

Fortive upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

MRK

Merck

$88.84

0.09 (0.10%)

, ARQL

ArQule

$9.67

0.15 (1.58%)

06:49
12/09/19
12/09
06:49
12/09/19
06:49
Hot Stocks
Merck to acquire ArQule for $20 per share, or approximately $2.7B »

Merck (MRK) and ArQule…

MRK

Merck

$88.84

0.09 (0.10%)

ARQL

ArQule

$9.67

0.15 (1.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 11

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

COLD

Americold Realty Trust

$37.09

-0.31 (-0.83%)

06:49
12/09/19
12/09
06:49
12/09/19
06:49
Downgrade
Americold Realty Trust rating change  »

Americold Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETNB

89bio

$28.38

0.86 (3.13%)

06:48
12/09/19
12/09
06:48
12/09/19
06:48
Initiation
89bio initiated  »

89bio initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$151.77

1.85 (1.23%)

, DELL

Dell Technologies

$47.09

-0.255 (-0.54%)

06:48
12/09/19
12/09
06:48
12/09/19
06:48
Periodicals
China orders state offices to remove foreign hardware, software, FT reports »

China's Communist…

MSFT

Microsoft

$151.77

1.85 (1.23%)

DELL

Dell Technologies

$47.09

-0.255 (-0.54%)

HPQ

HP Inc.

$20.50

0.17 (0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 11

    Dec

  • 27

    Feb

WCC

Wesco

$55.24

1.14 (2.11%)

06:48
12/09/19
12/09
06:48
12/09/19
06:48
Conference/Events
Wesco management to meet with KeyBanc »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

  • 11

    Dec

CRVS

Corvus Pharmaceuticals

$4.26

-0.36 (-7.79%)

06:46
12/09/19
12/09
06:46
12/09/19
06:46
Recommendations
Corvus Pharmaceuticals analyst commentary  »

Corvus pipeline updates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRL

Charles River

$146.23

1.765 (1.22%)

06:45
12/09/19
12/09
06:45
12/09/19
06:45
Recommendations
Charles River analyst commentary  »

Charles River price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY-R

Bristol-Myers Squibb CVR

$0.00

(0.00%)

, BMY

Bristol-Myers

$59.94

0.435 (0.73%)

06:42
12/09/19
12/09
06:42
12/09/19
06:42
Recommendations
Bristol-Myers Squibb CVR, Bristol-Myers analyst commentary  »

Bristol-Myers Squibb CVR…

BMY-R

Bristol-Myers Squibb CVR

$0.00

(0.00%)

BMY

Bristol-Myers

$59.94

0.435 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 11

    Dec

MRNS

Marinus Pharmaceuticals

$1.32

0.06 (4.76%)

06:39
12/09/19
12/09
06:39
12/09/19
06:39
Hot Stocks
Marinus Pharmaceuticals provides update on orphan seizure programs »

Marinus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.